Fasting and Cancer: What Helps, What Hurts, and When to Hold Off

Fasting is not a cancer treatment, and it is not safe for everyone. The gentlest and best-studied version is a consistent overnight break from food of about 12 to 13 hours, which can support blood sugar balance and sleep for people who are eating well and holding their weight. Longer fasts during treatment are still being studied and belong only under the supervision of your oncology team, because for many people in active treatment, getting enough fat and protein comes first.

As an Oncology Nutrition Consultant (ONC) and a brain cancer survivor myself, fasting is one of the questions I hear most often. Below, I walk through what the research actually shows, how to tell the different types of fasting apart, and how to decide whether any of it fits your situation right now.

Start Here: Who Should Not Fast

Before we talk about potential benefits, I want to start with safety. Fasting is not appropriate for everyone, and for some people it can do real harm.

Malnutrition and loss of muscle are common during cancer and are linked to poorer treatment outcomes. This is why the European Society for Clinical Nutrition and Metabolism (ESPEN) recommends that everyone with cancer be screened regularly for nutritional risk, and that energy and protein needs be met rather than restricted, especially for anyone who is losing weight.¹ ²

Please do not try fasting on your own if any of these apply to you:

• Unintentional weight loss, even a few pounds you weren't trying to lose
• Low appetite or low food intake, this includes feelings of early fullness or taste changes.
• Frailty or loss of muscle strength, or a care team has flagged you as at risk for malnutrition.
• Diabetes medications or any medication that lowers blood sugar, since skipping meals can cause dangerously low blood sugar. Fasting may still be possible with diabetes or pre-diabetes, but this is on a case by case basis.
• Vomiting or diarrhea, which already make it hard to stay nourished and hydrated.
• A current or past eating disorder, or a history of restrictive eating; in this case, fasting is not the right tool, and I recommend working with an eating-disorder specialist.

If one of these describes you, that's not a failure. It simply means your body's priority right now is nourishment, and there are many other ways to support your body's terrain that don't involve going without food.

Not All Fasting Is the Same

"Fasting" covers everything from a slightly earlier dinner to several days without food. These approaches carry very different levels of evidence and risk, so it helps to name them clearly.

The overnight window is the one I discuss most with clients, because it is the most accessible. The further down the table you go, the more metabolic flexibility (your body's ability to switch between fuel sources) and supervision is needed.

What the Research Tells Us

Why researchers are interested. Much of the excitement comes from animal studies. In mice, repeated cycles of fasting slowed the growth of several types of tumors and made many cancer cell types more sensitive to chemotherapy.⁴

Fasting lowers insulin and a growth-promoting hormone called IGF-1, and shifts healthy cells into a protective, repair-focused mode that many cancer cells struggle to match.⁵

A 2024 review of fasting, fasting-mimicking, and ketogenic approaches found promising results, but stressed that cancers differ in which fuels they rely on, so what helps with one type may not help with another. The authors also noted that most of this evidence still comes from cell and animal studies, and that sticking with these diets is a real challenge in human trials.⁶

Overnight fasting. A 2024 review in Nutrients updating the American Cancer Society's diet guidelines found that a longer overnight fast may play a role in lowering cancer risk, while also noting that excessive fasting may harm quality of life. The authors considered the evidence on time-restricted eating still too uncertain to add to formal guidelines.⁷ One study it highlights, from Spain, linked a longer nighttime fast and an earlier breakfast with lower prostate cancer risk.⁸

The most cited human study in this area followed 2,413 women with early-stage breast cancer for about seven years. Women who fasted fewer than 13 hours overnight had a 36% higher risk of breast cancer recurrence than those who fasted 13 hours or more. Longer overnight fasting was also linked to better long-term blood sugar control (a test result called HbA1c) and longer sleep. There was no statistically clear difference in cancer mortality.⁹ This was an observational study, which means it shows a link, not proof that fasting caused the difference, and it was specific to early-stage breast cancer.

Animal research adds another layer for people carrying extra weight. In obese mice with triple-negative breast cancer, alternate-day fasting lowered blood sugar, cholesterol, and inflammatory signals and slowed tumor growth, though the effects were weaker in lean mice.¹⁰ It's a mouse study, not a human one, but it fits the idea that fasting's potential benefits may depend on a person's overall metabolic health.

Fasting around chemotherapy. In a small safety study of 20 people receiving platinum-based chemotherapy, fasting for up to 72 hours around treatment was found to be safe and feasible, with side effects of the fast itself mostly limited to fatigue, headache, and dizziness.¹¹

In the larger DIRECT trial, 131 women with HER2-negative early breast cancer were randomly assigned to a fasting-mimicking diet for the three days before and the day of each chemotherapy dose, or to their usual diet. Side effects were similar between groups, and tumors were more likely to shrink on imaging in the fasting-mimicking group.¹²

A 2022 study of 101 people with various cancers found that a fasting-mimicking diet was safe and well tolerated alongside standard treatment, lowered blood sugar and growth-factor levels, and shifted several immune markers in a favorable direction. The researchers were clear that larger trials are still needed to know whether this improves outcomes.¹³

A follow-up analysis of that same trial described five people with advanced cancers (small cell lung, pancreatic, colorectal, and triple-negative breast cancer) who had complete, long-lasting responses when the fasting-mimicking diet was combined with their standard treatment.¹⁴

Colorectal cancer. This is one area where the lab research is especially interesting. In mouse and cell studies, a 48-hour fast before a chemotherapy commonly used for colorectal cancer slowed tumor growth more than the chemotherapy alone, by changing how the cancer cells produce energy.¹⁵

Another mouse study looked at colorectal cancers with a KRAS mutation, a genetic change that makes some colorectal cancers harder to treat. Combining a fasting-mimicking diet with high-dose vitamin C slowed tumor growth, and in some mice shrank tumors, more than either approach alone.¹⁶ The doses used in that research are far beyond what food or typical supplements provide, and high-dose vitamin C should only be given under medical supervision.

One of the five exceptional responders above had metastatic colorectal cancer,¹⁴ and a small UK trial called SWiFT is testing whether a 36-hour water-only fast before chemotherapy is practical for people with stage 2 or 3 colorectal cancer.¹⁷ 

Ketones and brain tumors. When you go long enough without food, your body shifts toward burning fat and making ketones, an alternative fuel. A 2022 review describes how ketones act as signaling molecules as well as fuel, and why their effects on cancer cells may depend on the tumor type.¹⁸

Ketogenic metabolic therapy is being explored most actively in brain tumors. In one surgeon's series of 16 people with glioma who stayed in nutritional ketosis for at least four months, all had a complete or partial tumor response while on the therapy.¹⁹ 

Where conventional and integrative perspectives meet. In the integrative and naturopathic oncology world, Dr. Nasha Winters' Terrain Ten framework treats blood sugar balance and metabolic flexibility as core parts of the terrain, and uses fasting as one individualized tool alongside conventional care, never as a stand-alone answer.²⁰

The terrain view also pays close attention to the gut microbiome. In mice with an autoimmune disease of the brain and spinal cord, intermittent fasting reshaped gut bacteria in ways that calmed inflammation.²¹ That study wasn't about cancer, but it's one reason integrative practitioners see the microbiome as part of how fasting may influence the body.

Both perspectives (conventional and integrative oncology) agree on more than you might expect: an overnight fast is low risk for most well-nourished people, and longer fasts need supervision and are not appropriate for anyone losing weight. Where they differ is mostly in how strongly to lean in before larger trials are finished.

No credible source on either side supports the idea that fasting, or any restrictive diet, cures cancer.

But I will say, if  fasting is safe for you, as approved by your medical team, there's little harm in trying it. 

What This Means in Real Life

If you're eating well, holding a steady weight, and your care team agrees, here is how I'd approach this with a client. Notice that most of it is about when and what you eat, not eating less.

1. Start with a consistent overnight break. Aim for about 12 hours between your last bite at night and your first bite in the morning, and only move toward 13 if it feels easy. A simple version: finish dinner by 7 pm and eat breakfast around 7 or 8 am.
2. Close the kitchen, not your plate. Skip the late-night snacks rather than skipping meals. A slightly bigger breakfast and lunch with a lighter dinner often makes the overnight window effortless.
3. Make the eating window nourishing. Build each meal around protein, colorful vegetables, fiber-rich whole foods, and healthy fats. A Mediterranean-style pattern has some of the most consistent research behind it for lowering cancer risk.⁷
4. Stay hydrated overnight. Water and caffeine-free herbal tea are fine during the fasting window.
5. Protect your sleep. An earlier last meal often supports better sleep, and sleep was one of the factors linked to longer overnight fasting in the breast cancer research.⁹
6. Keep an eye on your body. Check your weight once a week. Stop and talk with your care team if you notice unintended weight loss, dizziness, shakiness, unusual fatigue, or a drop in appetite.
7. Leave longer fasts to supervised settings. Don't try prolonged fasting or a fasting-mimicking diet at home during treatment without your oncology team's approval. If you're curious, ask whether there's a clinical trial you might qualify for.

Questions to bring to your next appointment:

• Is my weight stable enough to consider a longer overnight break?
• Do any of my medications need to be taken with food, or affect my blood sugar?
• Does my type of cancer or treatment plan change whether fasting is appropriate?
• Is there a clinical trial studying fasting or a fasting-mimicking diet for my diagnosis?
• Could labs like HbA1c (your average blood sugar) or the neutrophil-to-lymphocyte ratio (an inflammation signal from a routine blood count that's being studied as a marker of metabolic health²²) help track how my body is responding?

During Treatment vs. Risk Reduction

The same word, "fasting," means something very different depending on where you are right now. This is the most important distinction in this whole post.

During active treatment

During chemotherapy, radiation, immunotherapy, or recovery from surgery, your body is doing an enormous amount of repair work. That work needs fuel.

Adequate energy and protein help you protect muscle, keep your strength up, and stay on your treatment schedule, and ESPEN's guidance reflects that priority.²

Fasting may improve cell sensitivity to chemotherapy agents, but this dependent upon the cancer type. Your situation, weight, and labs should all be considered before making any type of fasting a part of your care plan. 

After treatment and into survivorship

Once treatment is behind you, your weight has stabilized, and your appetite has returned, a consistent overnight break can become one part of a broader plan to support your body's terrain. This is where the breast cancer research on 13-hour overnight fasting is most relevant, though it hasn't been confirmed in a randomized trial.⁹

Risk Reduction

If you don't have a cancer diagnosis and are focused on lowering your risk, the overnight window fits well within a whole-food, Mediterranean-style way of eating.⁷

Researchers are still sorting out whether fasting itself changes cancer risk, or whether its benefits come mostly from better blood sugar balance, sleep, and weight.³

For example, in adults carrying extra weight, intermittent fasting lowered insulin levels and improved insulin resistance about as well as cutting calories every day, though it wasn't better than daily calorie reduction.²⁴

For people at higher risk of liver cancer, such as those with fatty liver disease, a 2022 review found that intermittent fasting may improve weight, insulin resistance, and liver health, which could in theory lower liver cancer risk. The cancer-specific evidence is still mostly from animal studies, and the authors cautioned that fasting can be harmful for people with advanced cirrhosis.²⁵

Fasting also isn't the only tool for blood sugar balance, which matters if you have prediabetes or diabetes and fasting isn't a good fit for you.

Berberine, a plant compound, lowered fasting blood sugar and HbA1c in two small trials of adults with prediabetes,²⁶ ²⁷ and animal studies suggest it may work partly through how muscles take up sugar²⁸ and through the gut microbiome.²⁹

Berberine can interact with several medications, including some cancer and transplant drugs, and isn't appropriate during pregnancy or breastfeeding, so please review it with your care team before trying it.³⁰

Cancer type matters in every one of these stages. Most of the strongest fasting research so far is in breast cancer. What applies to early-stage breast cancer may not apply to cancers where weight loss is common early on, such as pancreatic, stomach, esophageal, lung, or head and neck cancers. That's exactly why a general article like this can point you in a direction, but can't make the decision for you.

Who Needs Individualized Guidance?

Honestly, almost everyone affected by cancer benefits from a personalized look before changing when and how they eat. It's especially important if you are:

• In active treatment. Your needs can change from one cycle to the next, and fasting decisions should be coordinated with your oncology team.
• Losing weight or muscle. Unintentional weight loss is a signal to prioritize nourishment, not restriction.
• Living with digestive symptoms. Nausea, diarrhea, mouth sores, early fullness, or taste changes all affect how much you can safely go without food.
• Taking medications that interact with meal timing. Some medications need to be taken with food, and others affect blood sugar. Your oncologist and pharmacist are the right people to review these with you.
• Carrying a genetic predisposition. An inherited risk (such as a BRCA variant) or nutrigenomic tendencies in how your body regulates blood sugar, inflammation, or nutrient needs can shape which approach makes sense for you.
• Someone with a history of disordered eating. Fasting can reopen old patterns. Please work with an eating-disorder specialist, who can help you find a safe way to nourish your body.

When you're ready for guidance that fits your situation, talk with a practitioner trained in integrative oncology, such as a naturopathic oncologist, or your Oncology Nutrition Consultant (ONC).

Frequently Asked Questions

Is fasting safe during chemotherapy?

For some people, short supervised fasts around chemotherapy have been safe in clinical studies.¹¹ ¹² ¹³ But those studies carefully selected participants, often excluded people who were underweight or had diabetes, and monitored them closely. Fasting during chemotherapy should only happen with your oncology team's approval, or within a clinical trial.³

Can fasting starve cancer cells or cure cancer?

No. Lab and early human research suggests fasting may make cancer cells more sensitive to treatment while helping protect healthy cells, partly by lowering growth signals such as insulin and a growth-promoting hormone called IGF-1, but this is still being studied.⁴ ⁵ ¹² ¹³ No fasting protocol has been shown to cure cancer, and going without enough food can weaken a body that is working hard to heal itself.

How long should I fast overnight?

For most well-nourished adults who are holding their weight, about 12 to 13 hours is the range most often discussed in the research.⁹ Start with 12, and only extend it after a 12 hour fast feels easy and your weight stays stable.

What is a fasting-mimicking diet, and should I try one?

A fasting-mimicking diet is a short, structured meal plan, usually 3 to 5 days, that is low in carbohydrates and protein, and high in healthy fats. It's designed to create some of the same metabolic effects as fasting while still providing food. Early trials are encouraging, particularly in breast cancer,¹² ¹³ but it is not a do-it-yourself project during treatment. Talk with your oncology team first.

Can I fast if I'm losing weight during treatment?

No. If you are losing weight without trying, your priority is getting enough energy and protein to protect your muscle and strength.¹ ² Work with your care team on ways to increase your intake rather than restrict it.

Get Support That Fits Your Body

Fasting can be a helpful tool for some people and a harmful one for others, and the difference comes down to your cancer type, your treatment, your weight and appetite, your medications, and your genetics. You don't have to figure that out alone.

As an Oncology Nutrition Consultant (ONC) and nutrigenomics analyst, I work with clients as a guide, patient advocate, and personal researcher. Together, we build a plan that supports your body's terrain, coordinates with your oncology team, and puts nourishment first when that's what your body needs.

• I offer 1:1 oncology nutrition counseling by telehealth to clients in many US states.
• Nutrigenomics analysis with the Nutrition Genome test is open to clients anywhere, and can reveal genetic tendencies that shape how your body handles blood sugar, inflammation, and nutrient needs.

Schedule a Discovery Call to talk through whether fasting, or a different approach, makes sense for you.

Disclaimer

Our Content, Programs, Services, Offerings, and/or Products are solely for informational and inspirational use as a self-help tool and are not intended to be professional medical advice, mental health advice, or medical nutrition therapy of any kind. We recommend to always speak to a licensed medical provider prior to making any changes to your routine, including, but not limited to, nutrition, exercise, dietary supplementation, and use of home products and devices and personal care products. We are not trained or licensed to, and do not, diagnose or treat any diseases, disorders, illnesses, injuries or conditions and none of the Content, Programs, Services, Offerings, and/or Products should be taken as medical advice, prescription, disease diagnosis, disease prevention, or disease treatment. We are not a substitute for a licensed physician or other appropriate healthcare provider.

Citations

1. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11-48. doi:10.1016/j.clnu.2016.07.015 https://pubmed.ncbi.nlm.nih.gov/27637832/
2. Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898-2913. doi:10.1016/j.clnu.2021.02.005 https://doi.org/10.1016/j.clnu.2021.02.005
3. Clifton KK, Ma CX, Fontana L, Peterson LL. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin. 2021;71(6):527-546. doi:10.3322/caac.21694 https://pubmed.ncbi.nlm.nih.gov/34383300/
4. Lee C, Raffaghello L, Brandhorst S, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4(124):124ra27. doi:10.1126/scitranslmed.3003293 https://doi.org/10.1126/scitranslmed.3003293
5. Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014;19(2):181-192. doi:10.1016/j.cmet.2013.12.008 https://doi.org/10.1016/j.cmet.2013.12.008
6. Menyhárt O, Győrffy B. Dietary approaches for exploiting metabolic vulnerabilities in cancer. Biochim Biophys Acta Rev Cancer. 2024;1879(2):189062. doi:10.1016/j.bbcan.2023.189062 https://doi.org/10.1016/j.bbcan.2023.189062
7. Torres Á, Quintanilla F, Barnafi E, et al. Dietary interventions for cancer prevention: an update to ACS international guidelines. Nutrients. 2024;16(17):2897. doi:10.3390/nu16172897 https://www.mdpi.com/2072-6643/16/17/2897
8. Palomar-Cros A, Espinosa A, Straif K, et al. The association of nighttime fasting duration and prostate cancer risk: results from the multicase-control (MCC) study in Spain. Nutrients. 2021;13(8):2662. doi:10.3390/nu13082662 https://doi.org/10.3390/nu13082662
9. Marinac CR, Nelson SH, Breen CI, et al. Prolonged nightly fasting and breast cancer prognosis. JAMA Oncol. 2016;2(8):1049-1055. doi:10.1001/jamaoncol.2016.0164 https://doi.org/10.1001/jamaoncol.2016.0164
10. Son DS, Done KA, Son J, et al. Intermittent fasting attenuates obesity-induced triple-negative breast cancer progression by disrupting cell cycle, epithelial-mesenchymal transition, immune contexture, and proinflammatory signature. Nutrients. 2024;16(13):2101. doi:10.3390/nu16132101 https://www.mdpi.com/2072-6643/16/13/2101
11. Dorff TB, Groshen S, Garcia A, et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer. 2016;16:360. doi:10.1186/s12885-016-2370-6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901417/
12. de Groot S, Lugtenberg RT, Cohen D, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020;11(1):3083. doi:10.1038/s41467-020-16138-3 https://pubmed.ncbi.nlm.nih.gov/32576828/
13. Vernieri C, Fucà G, Ligorio F, et al. Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Discov. 2022;12(1):90-107. doi:10.1158/2159-8290.CD-21-0030 https://aacrjournals.org/cancerdiscovery/article/12/1/90/675618/Fasting-Mimicking-Diet-Is-Safe-and-Reshapes
14. Ligorio F, Fucà G, Provenzano L, et al. Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: a sub-analysis of the NCT03340935 trial. Eur J Cancer. 2022;172:300-310. doi:10.1016/j.ejca.2022.05.046 https://doi.org/10.1016/j.ejca.2022.05.046
15. Bianchi G, Martella R, Ravera S, et al. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. Oncotarget. 2015;6(14):11806-11819. doi:10.18632/oncotarget.3688 https://pubmed.ncbi.nlm.nih.gov/25909219/
16. Di Tano M, Raucci F, Vernieri C, et al. Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nat Commun. 2020;11(1):2332. doi:10.1038/s41467-020-16243-3 https://doi.org/10.1038/s41467-020-16243-3
17. Short-term Water-only Fasting prior to chemotherapy Trial (SWiFT). ISRCTN registry. ISRCTN17994717. https://www.isrctn.com/ISRCTN17994717
18. Hwang CY, Choe W, Yoon KS, et al. Molecular mechanisms for ketone body metabolism, signaling functions, and therapeutic potential in cancer. Nutrients. 2022;14(22):4932. doi:10.3390/nu14224932 https://doi.org/10.3390/nu14224932
19. Smith KA, Hendricks BK, DiDomenico JD, et al. Ketogenic metabolic therapy for glioma. Cureus. 2022;14(6):e26457. doi:10.7759/cureus.26457 https://doi.org/10.7759/cureus.26457
20. Winters N, Higgins Kelley J. The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies. Chelsea Green Publishing; 2017.
21. Cignarella F, Cantoni C, Ghezzi L, et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab. 2018;27(6):1222-1235.e6. doi:10.1016/j.cmet.2018.05.006 https://doi.org/10.1016/j.cmet.2018.05.006
22. Hashemi Moghanjoughi P, Neshat S, Rezaei A, Heshmat-Ghahdarijani K. Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes? Endocr Pract. 2022;28(3):342-348. doi:10.1016/j.eprac.2021.11.083 https://doi.org/10.1016/j.eprac.2021.11.083
23. Icard P, Ollivier L, Forgez P, et al. Perspective: do fasting, caloric restriction, and diets increase sensitivity to radiotherapy? A literature review. Adv Nutr. 2020;11(5):1089-1101. doi:10.1093/advances/nmaa062 https://doi.org/10.1093/advances/nmaa062
24. Barnosky AR, Hoddy KK, Unterman TG, Varady KA. Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. Transl Res. 2014;164(4):302-311. doi:10.1016/j.trsl.2014.05.013 https://doi.org/10.1016/j.trsl.2014.05.013
25. Minciuna I, van Kleef LA, Stefanescu H, Procopet B. Is fasting good when one is at risk of liver cancer? Cancers (Basel). 2022;14(20):5084. doi:10.3390/cancers14205084 https://doi.org/10.3390/cancers14205084
26. Panigrahi A, Mohanty S. Efficacy and safety of HIMABERB® berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial. BMC Endocr Disord. 2023;23(1):190. doi:10.1186/s12902-023-01442-y https://doi.org/10.1186/s12902-023-01442-y
27. Wang L, Ge H, Wei G, Pong L, Wu L, Ye H. Berberine and prediabetes: a clinical observational study. J Diabetes Mellitus. 2020;10(4):209-221. doi:10.4236/jdm.2020.104017 https://doi.org/10.4236/jdm.2020.104017
28. Mi J, He W, Lv J, Zhuang K, Huang H, Quan S. Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats. Diabetes Metab Syndr Obes. 2019;12:1717-1725. doi:10.2147/DMSO.S211188 https://doi.org/10.2147/DMSO.S211188
29. Wang Y, Liu H, Zheng M, et al. Berberine slows the progression of prediabetes to diabetes in Zucker diabetic fatty rats by enhancing intestinal secretion of glucagon-like peptide-2 and improving the gut microbiota. Front Endocrinol (Lausanne). 2021;12:609134. doi:10.3389/fendo.2021.609134 https://doi.org/10.3389/fendo.2021.609134
30. Memorial Sloan Kettering Cancer Center. Berberine. About Herbs, Botanicals and Other Products. Accessed October 16, 2026. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/berberine